Published in Jpn J Exp Med on October 01, 1978
Encephalitis resulting from reactivation of latent herpes simplex virus in mice. J Virol (1984) 1.04
Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy. Trans Am Ophthalmol Soc (2000) 0.93
Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet (1988) 8.76
A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in S. flexneri 2a. Cell (1986) 4.88
Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A (1991) 2.87
Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev (1998) 2.82
C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci U S A (1994) 2.57
DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. Mol Cell Biol (1996) 2.44
Two species of human CRK cDNA encode proteins with distinct biological activities. Mol Cell Biol (1992) 2.30
Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with G alpha(i) Nature (1999) 2.23
Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study. J Gen Virol (1991) 2.05
Effects of protease and elastase from Pseudomonas aeruginosa on skin. Jpn J Exp Med (1975) 2.05
Interaction of azole antifungal agents with cytochrome P-45014DM purified from Saccharomyces cerevisiae microsomes. Biochem Pharmacol (1987) 2.01
CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol Cell Biol (1994) 1.92
In vivo studies on protease and elastase from Pseudomonas aeruginosa. Jpn J Exp Med (1975) 1.87
Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology (2000) 1.86
Evidence that DOCK180 up-regulates signals from the CrkII-p130(Cas) complex. J Biol Chem (1998) 1.72
Decreased tensile strength of an epidural catheter during its removal by grasping with a hemostat. Anesth Analg (2001) 1.72
Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine (2000) 1.63
Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine (1990) 1.62
Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Methods (1997) 1.62
Hair follicle involvement in herpes zoster: pathway of viral spread from ganglia to skin. Virchows Arch (1996) 1.56
Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine (1988) 1.55
Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and adipotropic infection. J Gen Virol (2000) 1.55
Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan. J Clin Microbiol (2001) 1.54
Amplification and detection of a single molecule of human immunodeficiency virus RNA. Virus Genes (1993) 1.53
Massive large bowel resection decreases bone strength and magnesium content but not calcium content of the femur in rats. Nutrition (2001) 1.53
Effect of re-treatment with gefitinib ('Iressa', ZD1839) after acquisition of resistance. Ann Oncol (2004) 1.48
Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology (1997) 1.44
Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence. J Virol (1994) 1.44
Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid. J Virol (2003) 1.43
Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus. J Virol (1990) 1.42
Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites. Br J Dermatol (2014) 1.40
An infectious DNA clone of HIV type 1 subtype C. AIDS Res Hum Retroviruses (1999) 1.40
Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immunol (1992) 1.40
Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur J Immunol (1992) 1.38
Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J Immunol (1996) 1.37
Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells. Mol Cell Biol (1993) 1.34
Expression cloning of a novel alpha 1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. J Biol Chem (1994) 1.33
Rap2 as a slowly responding molecular switch in the Rap1 signaling cascade. Mol Cell Biol (2000) 1.32
Yeast cytochrome P-450 catalyzing lanosterol 14 alpha-demethylation. II. Lanosterol metabolism by purified P-450(14)DM and by intact microsomes. J Biol Chem (1984) 1.30
High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. Am J Pathol (1999) 1.29
Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. Virology (1986) 1.29
The use of mice in the Sereny test as a virulence assay of shigellae and enteroinvasive Escherichia coli. Infect Immun (1986) 1.26
Studies on enteropathogenic activity of Vibrio parahaemolyticus using ligated gut loop model in rabbits. Jpn J Med Sci Biol (1974) 1.23
Detection of viral antigens in formalin-fixed specimens by enzyme treatment. Ann N Y Acad Sci (1983) 1.23
Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur J Immunol (1991) 1.22
An imported case of Lassa fever with late appearance of polyserositis. J Infect Dis (1988) 1.21
H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin. Immunology (1991) 1.20
Structural requirement of CRK SH2 region for binding to phosphotyrosine-containing proteins. Evidence from reactivity to monoclonal antibodies. J Biol Chem (1993) 1.20
Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection. J Gen Virol (1998) 1.19
Isolation of Borna disease virus from human brain tissue. J Virol (2000) 1.19
Yeast cytochrome P-450 catalyzing lanosterol 14 alpha-demethylation. I. Purification and spectral properties. J Biol Chem (1984) 1.16
Activation of C3G guanine nucleotide exchange factor for Rap1 by phosphorylation of tyrosine 504. J Biol Chem (1999) 1.16
Enteropathogenicity and enterotoxigenicity of human enteropathogenic Escherichia coli. Jpn J Med Sci Biol (1974) 1.16
Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.16
Baicalein, an alpha-glucosidase inhibitor from Scutellaria baicalensis. J Nat Prod (1998) 1.15
Extension of nasopharyngeal carcinoma and otitis media with effusion. Arch Otolaryngol Head Neck Surg (1988) 1.15
A single amino acid substitution converts cytochrome P450(14DM) to an inactive form, cytochrome P450SG1: complete primary structures deduced from cloned DNAS. Biochem Biophys Res Commun (1988) 1.15
L-Threonine dehydrogenase of chicken liver. Purification, characterization, and physiological significance. J Biol Chem (1981) 1.14
An endoplasmic reticulum protein, p180, is highly expressed in human cytomegalovirus-permissive cells and interacts with the tegument protein encoded by UL48. J Virol (2002) 1.14
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"? Exp Dermatol (2006) 1.13
Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine. Vaccine (1989) 1.13
Emerging components of the Crk oncogene product: the first identified adaptor protein. Cell Signal (1996) 1.13
Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies. Virology (2001) 1.12
Serological and virological evidence of a Hantaan virus-related enzootic in the United States. J Infect Dis (1985) 1.12
Demonstration of varicella-zoster virus antigens in the vitreous aspirates of patients with acute retinal necrosis syndrome. Ophthalmology (1988) 1.12
The primary structure of rat ribosomal protein L37a. Eur J Biochem (1989) 1.11
Premotor cortex neurons in macaques: activity before distal and proximal forelimb movements. J Neurosci (1986) 1.11
Structure-activity relationships of a new antifungal imidazole, AFK-108, and related compounds. Chem Pharm Bull (Tokyo) (2000) 1.11
Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein. J Gen Virol (1999) 1.11
Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr (1999) 1.10
Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit. Vaccine (1992) 1.10
Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma. J Med Virol (1999) 1.10
Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues. Brain (1992) 1.10
Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab Invest (2000) 1.09
Role of Crk oncogene product in physiologic signaling. Crit Rev Oncog (1997) 1.09
Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J Virol (2000) 1.09
Phosphorylation of CrkII adaptor protein at tyrosine 221 by epidermal growth factor receptor. J Biol Chem (1998) 1.07
Facial nerve paralysis induced by herpes simplex virus in mice: an animal model of acute and transient facial paralysis. Ann Otol Rhinol Laryngol (1995) 1.07
Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins. J Biol Chem (1996) 1.07
Enhancement of guanine-nucleotide exchange activity of C3G for Rap1 by the expression of Crk, CrkL, and Grb2. J Biol Chem (1997) 1.07
Metabolism of 32-hydroxy-24,25-dihydrolanosterol by purified cytochrome P-45014DM from yeast. Evidence for contribution of the cytochrome to whole process of lanosterol 14 alpha-demethylation. J Biol Chem (1987) 1.06
Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase. J Immunol Methods (1995) 1.06
The microsurgical revascularisation of resected segments of tibia in the dog. J Bone Joint Surg Br (1978) 1.06
Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I. Proc Natl Acad Sci U S A (1995) 1.06
Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB. Vaccine (1989) 1.05
Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child (1992) 1.05
Non-adherent cell-specific expression of DOCK2, a member of the human CDM-family proteins. Biochim Biophys Acta (1999) 1.04
Charting of daily weight pattern reinforces maintenance of weight reduction in moderately obese patients. Am J Med Sci (1992) 1.04
Characterization of Oita virus 296/1972 of Rhabdoviridae isolated from a horseshoe bat bearing characteristics of both lyssavirus and vesiculovirus. Arch Virol (2004) 1.04
Transmembrane signaling for adhesive regulation of desmosomes and hemidesmosomes, and for cell-cell datachment induced by pemphigus IgG in cultured keratinocytes: involvement of protein kinase C. J Investig Dermatol Symp Proc (1999) 1.04
Immunofluorescence studies of disseminated Hantaan virus infection of suckling mice. Infect Immun (1983) 1.02
Quantitative analyses of thalamic and cortical origins of neurons projecting to the rostral and caudal forelimb motor areas in the cerebral cortex of rats. Brain Res (1998) 1.02
Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine (1998) 1.01
Human herpesvirus 6 (HHV-6) infection in the central nervous system. Acta Paediatr Jpn (1992) 1.00
Progressive outer retinal necrosis caused by herpes simplex virus type 1 in a patient with acquired immunodeficiency syndrome. Ophthalmology (2000) 1.00
Sterol 14-demethylase P450 (CYP51) provides a breakthrough for the discussion on the evolution of cytochrome P450 gene superfamily. Biochem Biophys Res Commun (2000) 1.00
Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza. Vaccine (1990) 1.00
CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients. Leukemia (2012) 1.00